Fair values of financial instruments not carried at fair value and bases of valuation - assets |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation | | | | | | | | | | | | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
The table below provides the fair value levelling of assets held for sale and liabilities of disposal groups that have been classified as held for sale in accordance with IFRS 5. For further details, see Note 15. | | | | | | | | | Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale | | | | | | | | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | Transfers between Level 1 and Level 2 fair values | | | | | | | Designated and otherwise mandatorily measured at fair value | | | | | | | | | | | | | | | | | | | | | Transfers from Level 1 to Level 2 | | | | | | | | Transfers from Level 2 to Level 1 | | | | | | | | | | | | | | | | | | | | | | | | Transfers from Level 1 to Level 2 | | | | | | | | Transfers from Level 2 to Level 1 | | | | | | | |
| | | | | | | | | | Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3 | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains or losses recognised in profit or loss | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains less losses from financial investments held at fair value through other comprehensive income | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | – financial investments: fair value gains/(losses) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains or losses recognised in profit or loss relating to assets and liabilities held at 30 Jun 2025 | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | Total gains or losses recognised in profit or loss | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains less losses from financial investments held at fair value through other comprehensive income | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’) | | | | | | | | – financial investments: fair value gains/(losses) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains or losses recognised in profit or loss relating to assets and liabilities held at 30 Jun 2024 | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | |
1Included in ‘financial investments: fair value gains/(losses)’ in the current year and ‘exchange differences’ in the consolidated statement of comprehensive income. 2Includes $2.3bn of transfers in representing enhancements to the application of our levelling methodology, primarily impacting our Insurance business. | | | | | Fair values of financial instruments not carried at fair value on the balance sheet | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Reverse repurchase agreements – non-trading | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | |
| | | | | Fair values of financial instruments not carried at fair value on the balance sheet – assets and disposal groups held for sale | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | |
|
Fair values of financial instruments not carried at fair value and bases of valuation - liabilities |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation | | | | | | | | | | | | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
The table below provides the fair value levelling of assets held for sale and liabilities of disposal groups that have been classified as held for sale in accordance with IFRS 5. For further details, see Note 15. | | | | | | | | | Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale | | | | | | | | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | Transfers between Level 1 and Level 2 fair values | | | | | | | Designated and otherwise mandatorily measured at fair value | | | | | | | | | | | | | | | | | | | | | Transfers from Level 1 to Level 2 | | | | | | | | Transfers from Level 2 to Level 1 | | | | | | | | | | | | | | | | | | | | | | | | Transfers from Level 1 to Level 2 | | | | | | | | Transfers from Level 2 to Level 1 | | | | | | | |
| | | | | | | | | | Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3 | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains or losses recognised in profit or loss | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains less losses from financial investments held at fair value through other comprehensive income | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | – financial investments: fair value gains/(losses) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains or losses recognised in profit or loss relating to assets and liabilities held at 30 Jun 2025 | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | Total gains or losses recognised in profit or loss | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains less losses from financial investments held at fair value through other comprehensive income | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’) | | | | | | | | – financial investments: fair value gains/(losses) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains or losses recognised in profit or loss relating to assets and liabilities held at 30 Jun 2024 | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | |
1Included in ‘financial investments: fair value gains/(losses)’ in the current year and ‘exchange differences’ in the consolidated statement of comprehensive income. 2Includes $2.3bn of transfers in representing enhancements to the application of our levelling methodology, primarily impacting our Insurance business. | | | | | Fair values of financial instruments not carried at fair value on the balance sheet | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Reverse repurchase agreements – non-trading | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | |
| | | | | Fair values of financial instruments not carried at fair value on the balance sheet – assets and disposal groups held for sale | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | |
|